Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial.
Brandt-Jacobsen NH, Johansen ML, Rasmussen J, Forman JL, Holm MR, Faber J, Rossignol P, Schou M, Kistorp C. Brandt-Jacobsen NH, et al. Diabetes Metab. 2021 Jul;47(4):101190. doi: 10.1016/j.diabet.2020.08.005. Epub 2020 Sep 9. Diabetes Metab. 2021. PMID: 32919068 Clinical Trial.
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial.
Jürgens M, Schou M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Wiberg M, Brandt-Jacobsen NH, Gæde P, Rossing P, Faber J, Inzucchi SE, Gustafsson F, Kistorp C. Jürgens M, et al. Among authors: brandt jacobsen nh. J Am Heart Assoc. 2021 Aug 3;10(15):e020418. doi: 10.1161/JAHA.120.020418. Epub 2021 Jul 19. J Am Heart Assoc. 2021. PMID: 34278803 Free PMC article. Clinical Trial.
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial.
Ersbøll M, Jürgens M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Brandt-Jacobsen NH, Gæde P, Rossing P, Faber J, Inzucchi SE, Gustafsson F, Schou M, Kistorp C. Ersbøll M, et al. Among authors: brandt jacobsen nh. Int J Cardiovasc Imaging. 2022 Mar;38(3):579-587. doi: 10.1007/s10554-021-02443-5. Epub 2021 Oct 20. Int J Cardiovasc Imaging. 2022. PMID: 34669059 Clinical Trial.
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial.
Brandt-Jacobsen NH, Jürgens M, Hasbak P, Gaede P, Rossing P, Rasmussen JJ, Andersen CF, Forman JL, Faber J, Inzucchi SE, Gustafsson F, Schou M, Kistorp C. Brandt-Jacobsen NH, et al. Diabetes Obes Metab. 2023 Mar;25(3):844-855. doi: 10.1111/dom.14933. Epub 2023 Jan 3. Diabetes Obes Metab. 2023. PMID: 36484428 Free PMC article. Clinical Trial.
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes.
Jürgens M, Schou M, Hasbak P, Kjaer A, Wolsk E, Zerahn B, Brandt-Jacobsen NH, Gaede P, Rossing P, Faber J, Inzucchi SE, Gustafsson F, Kistorp C. Jürgens M, et al. Among authors: brandt jacobsen nh. Diabetes Obes Metab. 2023 Oct;25(10):2888-2896. doi: 10.1111/dom.15183. Epub 2023 Jul 3. Diabetes Obes Metab. 2023. PMID: 37395341 Clinical Trial.